Jack Phillips - Apr 26, 2022 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role
Chief Executive Officer
Signature
/s/ Steven Reichling, attorney-in-fact
Stock symbol
AXDX
Transactions as of
Apr 26, 2022
Transactions value $
-$82,034
Form type
4
Date filed
4/28/2022, 05:54 PM
Previous filing
Apr 6, 2022
Next filing
Jun 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXDX Common Stock Options Exercise $0 +168K +136.48% $0.00 292K Apr 26, 2022 Direct F1
transaction AXDX Common Stock Sale -$82K -83.7K -28.69% $0.98 208K Apr 28, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXDX Employee Restricted Stock Units Options Exercise $0 -168K -100% $0.00* 0 Apr 26, 2022 Common Stock 168K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
F2 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 28, 2022, the reporting person was granted a total of 168,396 restricted stock units, which vested April 26, 2022.